top
Search terms
Results 1 - 8 of 8 - ordered by :
Escardio

Vigorous physical activity one or two times a week is associated with the lowest death rates in patients with stable coronary artery disease, reports a study published today in the European Journal ...

Date : 27/09/2019
Escardio

Senior author Professor Philippe Gabriel Steg of Hospital Bichat, Paris, France said: “Treatment with ticagrelor and aspirin also increased major bleeding relative to aspirin alone, but there ...

Date : 01/09/2019
Escardio

Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Prior randomised trials found declines in composite outcomes with non-culprit ...

Date : 01/09/2019
Escardio

Dr. Kelley Branch Among patients with stable coronary artery disease (CAD) and/or peripheral artery disease (PAD), those with heart failure are at a higher risk of major adverse cardiovascular events ...

Date : 29/05/2018
Escardio

Patients with stable atherosclerotic vascular disease who take rivaroxaban (2.5mg twice daily) plus aspirin (100mg once daily) have better cardiovascular outcomes than those who take aspirin alone, ...

Date : 28/08/2017
Escardio

(1-3) Professor Philippe Gabriel Steg, principal investigator of the CLARIFY registry, said: “The optimal blood pressure target in patients with hypertension continues to be debated, especially ...

Date : 30/08/2016
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 21/10/2015
Escardio

In the overall study population treatment with ivabradine did not result in a significant reduction of the primary composite end point (Cardiovascular death, admission to hospital for acute MI and ...

Date : 31/08/2008